Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03389555 · ClinicalTrials.gov registry record · Phase 2
Ascorbic Acid, Corticosteroids, and Thiamine in Sepsis (ACTS) Trial
A Phase 2 study, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 205
- Enrollment target
NCT03389555 is a Phase 2 study that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 205 participants.
The verdict
NCT03389555, a Phase 2 study, has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 205 participants
- Enrollment target
Study Summary
In this study, we aim to determine whether the combination of Ascorbic Acid (Vitamin C), Thiamine (Vitamin B1), and Corticosteroids improves the trajectory of organ failure and reduces mortality in patients with sepsis and septic shock as compared to placebo.
Interventions
- DRUG Normal saline
- DRUG vitamin C, vitamin B1, hydrocortisone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 205 participants |
| Start Date | 2018-02-09 |
| Est. Completion | 2020-02-28 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03389555
The ClinicalTrials.gov registry entry for NCT03389555 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 205 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Normal saline is the first listed.
NCT03389555 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03389555 about?
NCT03389555 is a clinical study titled "Ascorbic Acid, Corticosteroids, and Thiamine in Sepsis (ACTS) Trial". In this study, we aim to determine whether the combination of Ascorbic Acid (Vitamin C), Thiamine (Vitamin B1), and Corticosteroids improves the trajectory of organ failure and reduces mortality in patients with sepsis and septic shock as compared to placebo.
What is the current status of trial NCT03389555?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 205 participants. The study started on 2018-02-09. Estimated completion is 2020-02-28.
What interventions are being tested in trial NCT03389555?
The interventions under investigation include: Normal saline (DRUG), vitamin C, vitamin B1, hydrocortisone (DRUG).
Who is sponsoring clinical trial NCT03389555?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.